MX365751B - Sustained release system based on agave-and chitosan for promoting the regeneration of dermal tissue. - Google Patents

Sustained release system based on agave-and chitosan for promoting the regeneration of dermal tissue.

Info

Publication number
MX365751B
MX365751B MX2014014481A MX2014014481A MX365751B MX 365751 B MX365751 B MX 365751B MX 2014014481 A MX2014014481 A MX 2014014481A MX 2014014481 A MX2014014481 A MX 2014014481A MX 365751 B MX365751 B MX 365751B
Authority
MX
Mexico
Prior art keywords
agave
regeneration
promoting
release system
chitosan
Prior art date
Application number
MX2014014481A
Other languages
Spanish (es)
Other versions
MX2014014481A (en
Inventor
Carlos Gonzalez Monterrubio Enrique
Alejandra Minjares Espinoza Lizette
Original Assignee
Carlos Gonzalez Monterrubio Enrique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlos Gonzalez Monterrubio Enrique filed Critical Carlos Gonzalez Monterrubio Enrique
Priority to MX2014014481A priority Critical patent/MX365751B/en
Publication of MX2014014481A publication Critical patent/MX2014014481A/en
Publication of MX365751B publication Critical patent/MX365751B/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention pertaining to the field of biomedicine and nanotechnology, refers to a controlled and prolonged release system of L-ascorbic acid based on nanocapsules of chitosan embedded in cellulose extracted from agave, for promoting the regeneration of dermal tissue, thereby facilitating the healing process. The synthesis of the material is carried out by two steps, using ultrasonication for the formation of the nanocapsules charged with L-ascorbic acid, and a subsequent agitation process and ultrasonication for being adhered to the matrix of cellulose.
MX2014014481A 2014-11-27 2014-11-27 Sustained release system based on agave-and chitosan for promoting the regeneration of dermal tissue. MX365751B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2014014481A MX365751B (en) 2014-11-27 2014-11-27 Sustained release system based on agave-and chitosan for promoting the regeneration of dermal tissue.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2014014481A MX365751B (en) 2014-11-27 2014-11-27 Sustained release system based on agave-and chitosan for promoting the regeneration of dermal tissue.

Publications (2)

Publication Number Publication Date
MX2014014481A MX2014014481A (en) 2016-05-26
MX365751B true MX365751B (en) 2019-05-30

Family

ID=56797829

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014014481A MX365751B (en) 2014-11-27 2014-11-27 Sustained release system based on agave-and chitosan for promoting the regeneration of dermal tissue.

Country Status (1)

Country Link
MX (1) MX365751B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019006995A (en) * 2019-06-13 2020-12-14 Brenda Silva Rubio A composite material with scaffolding function containing a controlled capsules release system for the regeneration of the dermal tissue and the preparation method thereof.

Also Published As

Publication number Publication date
MX2014014481A (en) 2016-05-26

Similar Documents

Publication Publication Date Title
BR112013030492A2 (en) method of producing a fabric product, fabric product produced by a process, treatment method, and treatment system
MX370853B (en) Formulations containing amorphous dapagliflozin.
SG10201809290SA (en) Compositions and Methods to Treating Hemoglobinopathies
MX2021006581A (en) Bacteria engineered to treat diseases associated with hyperammonemia.
MX356097B (en) Process for preparing therapeutic nanoparticles.
MX2021007268A (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl] amino}acetic acid, compositions, and uses thereof.
GT201300232A (en) MODULATION OF SIGNAL TRANSDUCER EXPRESSION AND TRANSCRIPTION ACTIVATOR 3 (STAT3)
WO2016061232A3 (en) Multiplexed shrnas and uses thereof
MX391536B (en) COMPOSITION AND METHOD FOR THE DIAGNOSIS AND TREATMENT OF DISEASES ASSOCIATED WITH NEURITE DEGENERATION.
BR112015006393A2 (en) method for producing a fabric product, fabric product produced by a process, and treatment method
BR112014029655A2 (en) tissue preparation device, and method for preparing tissue
EP4299121A3 (en) Method of using cyclodextrin
CL2017002242A1 (en) Method to treat a brain tumor
MY193694A (en) Membrane-adherent self-assembled systems for treatment of ocular disorders
MX2017015250A (en) Formation of cyclosporin a/cyclodextrin nanoparticles.
CA2909956C (en) Accelerated healing of eye injuries by angiotensin peptides
EP4275746A3 (en) Extracellular vesicles derived from osteoblastic lineage cells for therapeutic and diagnostic use
EA201992832A1 (en) SCREAM INTRODUCTION ADAMTS13
EP3129062A4 (en) Targeted polymerized nanoparticles for cancer treatment
MA40463A (en) Targeting micrornas for metabolic disorders
MX2016006544A (en) Withanolides useful for the treatment of neurodegenerative diseases.
PH12016501812A1 (en) Modified sulfamidase and production thereof
PH12014502834A1 (en) Pharmaceutical form for extended release of active substances
TR201907274T4 (en) Method for the Production of Dried Biocellulose.
GT201400146A (en) TOPICAL PHARMACEUTICAL COMPOSITIONS THAT INCLUDE BEXAROTENE AND CORTICOSTEROIDS

Legal Events

Date Code Title Description
FG Grant or registration